Bionime Corporation
4737
Rank in Stocks
#18528
Bionime Corporation, headquartered in Taichung, Taiwan, specializes in the... Bionime Corporation, headquartered in Taichung, Taiwan, specializes in the development, production, and global distribution of medical instruments. The company maintains a significant international presence, serving markets in countries such as China, Switzerland, the United States, Algeria, and Egypt. Its primary product line features blood glucose monitoring systems, along with essential complementary items like test strips and lancing devices. These healthcare solutions are supplied to a varied customer base, including hospitals, pharmacies, and other medical equipment enterprises. Beyond its core medical device business, Bionime also engages in providing biotechnology-related services, performing pharmaceutical analysis, and marketing high-precision tools. The company was founded in 2003.
Share Price
$1.69
Last synced: 2026-11-10
Market Cap
$130.76M
Change (1 day)
-3.14%
Change (1 year)
-17.03%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bionime Corporation (4737)
Category
Healthcare
Operating Margin for Bionime Corporation (4737)
Operating Margin as of November 2026 TTM: -17.96%
According to Bionime Corporation's latest financial reports, its current operating margin (TTM) is -17.96%. At the end of 2025 the company had an operating margin of -10.73%.
Operating Margin history for Bionime Corporation from 2009 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -17.96% | 67.38% |
| 2025 | -10.73% | 60.87% |
| 2024 | -6.67% | 777.63% |
| 2023 | -0.76% | -111.45% |
| 2022 | 6.64% | 68.10% |
| 2021 | 3.95% | -13.19% |
| 2020 | 4.55% | -43.97% |
| 2019 | 8.12% | -31.88% |
| 2018 | 11.92% | -12.67% |
| 2017 | 13.65% | -8.08% |
| 2016 | 14.85% | 25.95% |
| 2015 | 11.79% | 20.43% |
| 2014 | 9.79% | 5.50% |
| 2013 | 9.28% | 87.85% |
| 2012 | 4.94% | -62.32% |
| 2011 | 13.11% | -20.69% |
| 2010 | 16.53% | 3.25% |
| 2009 | 16.01% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 28.37% | -101.58% |
US
|
|
| 12.36% | -100.69% |
FR
|
|
| 9.83% | -100.55% |
US
|
|
| 31.11% | -101.73% |
JP
|
|
| 9.87% | -100.55% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bionime Corporation's operating margin
What is Bionime Corporation's operating margin?
Bionime Corporation's operating margin is -17.96%, as of Nov 2026.
What was Bionime Corporation's operating margin in 2025?
In 2025, Bionime Corporation's operating margin was -10.73%, compared with -6.67% in 2024.
How has Bionime Corporation's operating margin changed since 2020?
From 2020 to 2025, Bionime Corporation's operating margin was highest in 2022 (6.64%) and lowest in 2025 (-10.73%).
How does Bionime Corporation's operating margin compare with similar companies?
Bionime Corporation's operating margin (-17.96%) is lower than that of all 5 similar companies listed above. The highest among them is HOYA Corporation, with 31.11%.